IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 30
Titolo Data di pubblicazione Autore(i) File
Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients 1-gen-2020 Gangat, N.; Morsia, E.; Foran, J. M.; Palmer, J. M.; Elliott, M. A.; Tefferi, A.
WHO defined chronic eosinophilic leukemia, not otherwise specified (CEL, NOS): A contemporary series from the Mayo Clinic 1-gen-2020 Morsia, E.; Reichard, K.; Pardanani, A.; Tefferi, A.; Gangat, N.
Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patients 1-gen-2020 Morsia, Erika; Mccullough, Kristen; Joshi, Maansi; Cook, Joselle; Alkhateeb, Hassan B; Al-Kali, Aref; Begna, Kebede; Elliott, Michelle; Hogan, William; Litzow, Mark; Shah, Mithun; Pardanani, Animesh; Patnaik, Mrinal; Tefferi, Ayalew; Gangat, Naseema
IDH2 Inhibitor Therapy in Relapsed and Refractory Acute Myeloid Leukemia: A Single Institution Experience 1-gen-2020 Li, M; Morsia, E; Wee, Ce; Mccullough, K; Al-Kali, A; Hogan, Wj; Patnaik, Mm; Tefferi, A; Gangat, N
Paraoxonase-2 in cutaneous T cell lymphomas. 1-gen-2021 Filosa, A; Molinelli, E; Morsia, E; Emanuelli, M; Goteri, G
Anticoagulation and vessel recanalization in cirrhotic patients with splanchnic vein thrombosis: A multidisciplinary “real life” experience 1-gen-2021 Rupoli, S.; Fiorentini, A.; Morsia, E.; Svegliati-Baroni, G.; Micucci, G.; Maroni, L.; Garvey, K. B.; Snr, A. F.; Snr, A. R.; Da Lio, L.; Benedetti, A.; Offidani, M.; Olivieri, A.; Giuseppe, T.
Expression of Paraoxonase-2 in Different Stages of Cutaneous T Cell Lymphoma: Is It a Potential Biomarker for Aggressiveness? 1-gen-2021 Morsia, E; Rupoli, S; Molinelli, E; Sartini, D; Offidani, A; Emanuelli, M; Salvolini, E; Olivieri, A; Goteri, G
Epidemiology and Risk Factors for Infections in Myelodysplastic Syndromes 1-gen-2021 Poloni, A; Carturan, A; Pianelli, M; Morsia, E; Lame, D; Olivieri, A
Myeloproliferative Neoplasms with Monocytosis 1-gen-2021 Morsia, Erika; Gangat, Naseema
Long-Term Efficacy of Psoralen Plus Ultraviolet a Irradiation and Low-Dose Interferon-Alpha Therapy According to Conventional and Emerging Clinical Endopoints of Early Stage Cutaneous T Cell Lymphoma 1-gen-2021 Rupoli, S; Goteri, G; Morsia, E; Torre, E; Garvey, Kb; Giantomassi, F; Campanati, A; Offidani, Am; Brandozzi, G; Giorgio, M; Simonacci, M; Olivieri, A
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 1-gen-2021 Morsia, E.; Goteri, G.; Torre, E.; Garvey, K. B.; Discepoli, G.; Tassoni, A.; Mancini, S.; Giantomassi, F.; Poloni, A.; Olivieri, A.; Rupoli, S.
Myelofibrosis: challenges for preclinical models and emerging therapeutic targets 1-gen-2021 Morsia, E.; Gangat, N.
Mutations and thrombosis in essential thrombocythemia 1-gen-2021 Guglielmelli, P.; Gangat, N.; Coltro, G.; Lasho, T. L.; Loscocco, G. G.; Finke, C. M.; Morsia, E.; Sordi, B.; Szuber, N.; Hanson, C. A.; Pardanani, A.; Vannucchi, A. M.; Tefferi, A.
P1045: IS JAK2V617F BUT NOT CALR AS DRIVER MUTATION ENOUGH BY ITSELF IN THE PATHOGENESIS OF UNUSUAL TYPE VENOUS THROMBOSIS IN MPN PATIENTS? 1-gen-2022 Morsia, E.; Torre, E.; Tarantino, G.; Svegliati Baroni, G.; Goteri, G.; Mancini, S.; Tassoni, A.; Alessandro, F.; Olivieri, A.; Rupoli, S.
Molecular Pathogenesis of Myeloproliferative Neoplasms: From Molecular Landscape to Therapeutic Implications 1-gen-2022 Morsia, E.; Torre, E.; Poloni, A.; Olivieri, A.; Rupoli, S.
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 1-gen-2022 Offidani, M; Zizzo, C; Rupoli, S; Federici, I; More, S; Bossi, A; Manieri, Vm; Petrucci, Mt; Di Toritto, Tc; Brunori, M; Gozzetti, A; Tordi, A; Fazio, F; Lisi, C; Melaccio, A; Ciuffreda, L; Falcone, Ap; Fioritoni, F; Gentili, S; Siniscalchi, A; Trastulli, F; Corvatta, L; Morsia, E; Olivieri, A; Duro, G
Clinico-Pathological, Cytogenetic and Molecular Similarities and Differences between Primary and Secondary Cutaneous Lymphomas 1-gen-2022 Uccella, S; Goteri, G; Maiorana, A; Donati, V; Tibiletti, Mg; Magnoli, F; Facchi, S; Merchiori, D; Morsia, E; Papotti, R; Bettelli, S; Forti, E; Galimberti, S; Rupoli, S; Filosa, A; Dardanis, D; Braglia, L; Pozzi, S; Sacchi, S
Frequency and Risk Factors for Venous Thromboembolism Among Patients with Multiple Myeloma or Aggressive Lymphoma: A 6-Year Single Center Retrospective Analysis 1-gen-2022 Morsia, E; Torre, E; Marrara, F; More, S; Petrini, M; Manieri, Vm; Gurgoglione, L; Gini, G; Offidani, M; Olivieri, A; Rupoli, S
Clinical Presentation, Risk Factors and Outcome of Splanchnic Venous Thrombosis: A Report on 305 Cases 1-gen-2022 Morsia, E; Torre, E; Marrara, F; Battila, I; Fiorentini, A; Scortechini, Ar; Offidani, M; Svegliati-Baroni, G; Bendia, E; Olivieri, A; Tarantino, G; Rupoli, S
Chronic Myelomonocytic Leukemia Diagnosis By Flow Cytometry: An Italian Center Experience 1-gen-2022 Lame, D; Caprino, M; Busilacchi, Em; Viola, N; Morsia, E; Pianelli, M; Kordasti, S; Olivieri, A; Poloni, A
Mostrati risultati da 1 a 20 di 30
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile